Ethypharm is a specialty pharmaceutical company focused on specific Central Nervous System (CNS) diseases and conditions, as well as Hospital Injectables.

Ethypharm

IPhone / Mobile Compatible

Viewport Meta

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

Google Analytics

HSTS

WordPress

LetsEncrypt

DoubleClick.Net

Strategic Planning & Development Director Chez Ethypharm

Alix WIDMER

Operations

Amol Patil

Head of HR, Group and Commercial

Andrea MCIPD

Medical Marketing Director

Barbara Lindberg

Engineering and Technical Group Director

Eric Pachner

Evangelos Tiganos

Regulatory Affairs Associate Director

Giovanna Cappellari

National Marketing Director

Isabell Chumi

Business Development and Marketing Director CDMO

Isabelle Cheval

Human Resources

Isabelle Guo

Pierre Belichard

Head of European commercial operations

Charlotte Haas

Chief Transformation and Communication Officer

Roseline Joannesse

V.P. Corporate Legal Affairs -Ethic and Compliance Officer

Hugues Lecat

Non Executive Chairman

Bertrand Deluard

President and CEO

Jean Pierre Bracquemart

Executive Vice President

Daniela Schulte

Chief Human Resources Officer

Cecile Paillous

Corporate Quality V.P.

Europe, Middle East, and Africa (EMEA) Health Care Acquired Companies

Europe, Middle East, and Africa (EMEA) Acquired Companies With Less Than $1B in Revenue (Top 10K)

European Union (EU) Acquired Companies With Less Than $500M in Revenue

Europe Acquired Companies With More Than 100 Employees (Top 10K)

Ethypharm designs formulate, develops, manufactures, and markets pharmaceutical products for the treatment of pains and addictions.

Franceau

Bourgogne

France

Europe

Buccal Drug Delivery System Market Growth Analysis with Investment Opportunities For 2024-2033

Ethypharm announces the appointment of Éric CHEVALIER as Group Human Resources Director

Argatroban business in Europe transferred to Ethypharm

Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China

Ethypharm announces the Appointment of Xavier LASSERRE as New Chief Commercial Officer

Bruno Ultra BARCELOS is appointed Managing Director of Ethypharm UK

The Supervisory Board appointed Denis DELVAL as CEO of the Ethypharm Group.

Users Marvel at Medical Cannabis' Myriad of Applications

HTML5

Microsoft Outlook

Wordpress

Office 365

jQuery

Adobe Flash

Google Drive

Modernizr

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 27, 2024 4:18 PM	b184b9ae
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 27, 2024 4:18 PM	8fb9234a
crunchbase trigger	general	Oct 31, 2024 9:55 AM	d0c18cc8
crunchbase profile	general	Oct 31, 2024 12:06 PM	44109f77
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	c12720a8
peers	general	Sep 27, 2024 4:18 PM	f3b8e0ca
news basic	general	Sep 27, 2024 4:18 PM	f1ed58e1
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:ETHYPHARM

Ethypharm